Overview of Dr. Falchi
Dr. Lorenzo Falchi is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from University of Perugia Faculty of Medicine and has been in practice since 2005. He also speaks multiple languages, including Italian. He specializes in hematologic oncology and is experienced in non-hodgkin lymphoma and immunotherapy.
Office
530 East 74th Street
New York, NY 10021
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2015 - 2019
Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia , 2012 - 2013- University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2011 - 2012
University of PerugiaSpecialist, Cum Laude, 2005 - 2009
University of Perugia Faculty of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2016 - 2026
NJ State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- ECFMGECFMG Certificate
Awards, Honors, & Recognition
- Future Leaders in Hematology Celgene, 2013
Clinical Trials
- A Study of Mosunetuzumab in People With Follicular Lymphoma Start of enrollment: 2022 May 27
Publications & Presentations
PubMed
- 90 citationsFollicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroupsConnie Lee Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith
Blood Cancer Journal. 2020-07-17 - 61 citationsBispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities.Lorenzo Falchi, Santosha A Vardhana, Gilles A Salles
Blood. 2023-02-02 - 85 citationsPhase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill
Journal of Clinical Oncology. 2021-06-25
Press Mentions
AbbVie, Genmab's Lymphoma Drug Epkinly Snags FDA Approval in Heated Blood Cancer RaceMay 19th, 2023- 'Remarkable' Study Shows Potential of Chemotherapy-Free Regimen for Follicular LymphomaDecember 13th, 2023
Committees
- Member, Society for immunotherapy of cancer - Early Career Scientists 2016 - Present
Professional Memberships
- Member
- Member
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
